IMC welcomes provincial and territorial focus on health funding
Ottawa, October 19, 2026 – Innovative Medicines Canada (IMC) welcomes the press release issued by provincial and territorial (PT) health […]
Partnering to champion policies that drive the discovery, development and delivery of transformative medicines and vaccines.
Ottawa, October 19, 2026 – Innovative Medicines Canada (IMC) welcomes the press release issued by provincial and territorial (PT) health […]
By Dr. Bettina Hamelin One year ago, the Ontario government made a decision: Patients shouldn’t have to wait up to […]
By Dr. Bettina Hamelin Canada has long punched above its weight in clinical trial activity: the rigorous, multi-stage research studies […]

Medicine Matters Canada is a new national public advocacy platform dedicated to improving patient access to innovative medicines and strengthening Canada’s life sciences sector.
The Health Research Foundation (HRF) is a non-profit organization that invests in Canadian applied health systems research and that contributes to the sustainability of the Canadian healthcare system for improved patient outcomes.

New medicines aren’t always available through public drug plans when Canadian patients need them. After Health Canada approves a new medicine as safe and effective, Canadians still wait an average of two years for access. These delays have existed for many years, yet little progress was made in 2025, with the notable exception of the Ontario government’s Funding Accelerated for Specific Treatments (FAST) Program.


Total yearly economic impact

Invested annually in research and development

High-quality Canadian jobs
Stay informed with timely, relevant content on key issues shaping our industry.